Φορτώνει......
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
PURPOSE: Apixaban is often coadministered with treatments for cardiovascular comorbidities, which may lead to unintended drug–drug interactions (DDIs). The effects of apixaban on pharmacokinetics (PK) of multidose Lanoxin(®) (digoxin) and single-dose Tenormin(®) (atenolol) and the effects of single-...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327911/ https://ncbi.nlm.nih.gov/pubmed/28260951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S115687 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|